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At  present,  there  are  no  efﬁcacious  vaccines  or effective  drugs  against  leishmaniasis;  therefore  new  and
innovative  control  methods  are  urgently  required.  One  way  to achieve  this  important  goal  is through  using
reverse  genetic  engineering  to evaluate  important  enzymes,  proteins  and  macromolecules.  One of  the
most important  enzymes  for Glycosylphosphatidylinositol  (GPI)  biosynthetic  pathways  is  GlcNAc-PI-de-
N-acetylase  (GPI12).  The  molecular  constructs  were  cloned  in Escherichia  coli strain  Top  10 and  conﬁrmed
by  molecular  methods  and  were  transfected  by electroporation  into  Leishmania  major.  We  demonstratedeishmaniasis
everse genetic engineering
PI12
ull mutant
that  two  alleles  of  the  GPI12  gene  in  L.  major  were  successfully  removed  and  enabling  the  generation  of
a  null  mutant,  which  supports  the  idea  that  GPI12  is  not  an  essential  gene  for the  growth  and  survival  of
Leishmania  and the  homozygous  knockouts  of  Leishmania  are  able  to  survive.  We  were  able  to produce
a  mutant  parasite  that  caused  no  damaged  to the  host.  Further  investigations  are  essential  to  check  the
safety  proﬁle  in  laboratory  animals.
©  2015  Elsevier  B.V.  All  rights  reserved.. Introduction
Leishmaniasis is a major public health problem occurring pri-
arily in tropical and sub-tropical countries (Alvar et al., 2012).
he control and prevention of leishmaniasis, especially in the case
f the zoonotic form, has been unsuccessful in most countries (Croft
t al., 2006; Khatami et al., 2007). No efﬁcacious and safe vaccine
as yet been found for human leishmaniasis and, treatment is the
nly major choice available to help control cutaneous leishmani-
sis (CL). At present, pentavalent antimonial compounds are the
tandard treatment for all forms of leishmaniasis, but the use of
∗ Corresponding author at: Leishmaniasis Research Centre, Kerman University of
edical Sciences, Kerman, Iran. Fax: +98 33257543.
∗∗ Corresponding author at: Cellular and Molecular Biology, Research Centre,
hahid Beheshti University of Medical Sciences, Tehran, Iran. Fax: +98 2122439956.
E-mail addresses: iraj.shariﬁ@yahoo.com (I. Shariﬁ), bahram 14@yahoo.com
B. Kazemi).
ttp://dx.doi.org/10.1016/j.actatropica.2015.10.025
001-706X/© 2015 Elsevier B.V. All rights reserved.these drugs are limited due to long duration of use, side-effects,
low efﬁcacy and increasing resistance.
One way to begin to create new treatments is through the
evaluation, by reverse genetic engineering, of important enzymes,
proteins and macromolecules. Ever since 1990, reverse genetic
tools have been used to study the genes in Leishmania (Clayton,
1999). Several reports have shown that some of these genes per-
form essential roles in different aspects such as survival, growth,
differentiation, and infectivity. In Leishmania major:  metallopro-
tease GP63 (Hassani et al., 2014), ATG5 protein (Williams et al.,
2012), NAD(P)H cytochrome b5 oxidoreductase (Mukherjee et al.,
2012), signal peptidase type I (Taheri et al., 2010), thymidine kinase
(Thiel et al., 2008), lipophosphoglycan (LPG) (Späth et al., 2003) and
leishmanolysin (Joshi et al., 2002); in Leishmania donovani: nitrore-
ductase (Wyllie et al., 2013), centrin (Selvapandiyan et al., 2004)
and ornithine decarboxylase (Jiang et al., 1999); and in Leishmania
mexicana: hexose transporter gene (Feng et al., 2013), cysteine pro-
teinases (Williams et al., 2006) and thymidine kinase (Garami and
Iiq, 2001).
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KFig. 1. The second step
In this study, the role of the GlcNAc-PI-de-N-acetylase (GPI12)
ene has been evaluated in the growth, survival and infectivity of L.
ajor by deletion of the gene through homologous recombination.
There are several cell surface glycoproteins of Leishmania that
re anchored to the cell surface by Glycosylphosphatidylinositol
GPI) glycolipids. This glycocalyx consists of GPI anchored lipophos-
hoglycans (LPG), GPI anchored glycoproteins, and free GPIs. The
ole of these molecules is to protect the parasite from degrading
nzymes such as a hydrolase and the alternate complement path-
ay (Naderer et al., 2004; Späth et al., 2000). The conserved protein
lycan that is linked to GPIs is Ethanolamine-P-Mana1-2Mana1-
Mana1-4GlcNH2 and is attached to the d-myo-inositol ring of
hosphatidylinositol (PI) (Ferguson et al., 1999). GPI anchors are
ynthesized in the endoplasmic reticulum membrane at different
tages and then attached to the proteins. So the GPI anchored pro-
eins are made then transferred through the secretory pathway to
he plasma membrane. In GPI biosynthesis the ﬁrst step is trans-
erring N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to PI as
 result, the GlcNAc-PI is formed. The catalysing enzyme in this
eaction is GPI-N-acetylglucosaminyltransferase (GPI-GnT). Then,
lcNAc-PI is de-N-acetylated to form GlcNH2-PI by GlcNAc-PI-de-
-acetylase (Chandra et al., 2010) (Fig. 1).
In Trypanosoma brucei bloodstream forms GPI biosynthesis is
ecessary; and has been examined as a potential as a drug target
Ferguson, 2000). Trypanosomal GlcNAc-PI-de-N-acetylase enzyme
s zinc metalloenzyme (Urbaniak et al., 2005) and GlcNAc-PI-de-N-
cetylase enzymes from T. brucei (Sharma et al., 1997) and L. major
Smith et al., 1997) were studied in vitro and little difference found
ompared to their human enzyme substrate. Investigation of spe-
iﬁc substrate GlcNR-PI analogue of GlcNAc-PI showed that when
his analogue was used no de-N-acetylated was observed in these
arasites but there was no effect on the human enzyme (Smith et al.,
001).
The goal of the present study is to delete the GPI12 gene and
valuate the in vivo and in vitro role of this gene and effect of its
eletion on the growth, survival and infectivity of L. major.
. Materials and methods
.1. Ethics statement
Animal experiments were performed in accordance with the
inistry of Health and Education of Iran Animal Care Guidelines
nd approved by the Ethics and Animal Care Committee of Ker-
an  University of Medical Sciences under Ethics Committee no.
MU.REC.1394.1. biosynthetic pathway.
2.2. Parasite
L. major Friedlin strain MRHO/IR/75/ER was  isolated from
infected BALB/c mice and then cultivated in DMEM (Dulbecco’s
Modiﬁed Eagles Medium) high glucose (4.5 g/l) media (Biosera,
France) with 10% foetal bovine serum (Gibco, UK), 40 mM  HEPES,
2 mM l-glutamine and 10,000 units of penicillin (base) and
10,000 g of streptomycin (base)/ml (Sigma, Germany) and incu-
bated at 26 ◦C. Log phase promastigotes (after 3 passages) were
used for transfection. Stationary phase promastigotes were used
for in vitro cell line J774 macrophage infectivity test also for in vivo
infection.
2.3. The construction of the replacement vectors
In order to design and make the molecular construct we
used pLEXSY-neo2 and pLEXSY-hyg2 vectors (Jena Bioscience,
Germany). These vectors contain gene markers which cause
aminoglycoside phosphotransferase and hygromycin phospho-
transferase, respectively, after they enter the genome. The selection
of these transfected parasites was  performed through constructs
which contain these markers that can be isolated by Neomycin and
Hygromycin antibiotics.
These vectors are made for the expression or gene knock-in in
Leishmania parasites which are required in order to modify for gene
knock out.
In order to perform trans-splicing and polyadenylation on
marker genes, utr2 and utr3 areas were required. Hence, we had
rearranged the order of the areas and place the ﬂank gene GPI12
area (which we intend to delete) after the utr2 and utr3 areas. The
sequence of these vectors were evaluated by web  cutter2 and neb
cutter2 software so that we could ﬁnd suitable locations for the
enzyme place. We  chose the enzymes BglII and KpnI in the left ﬂank
area and the enzymes FseI and BsrgI in the right ﬂank area.
The ﬂank area with enzymes were synthesized in the pGEM-
b1 vector by Bioneer company (South Korea) then we digested the
ﬂank areas by the above mentioned enzymes and situated them in
the pLESXY vectors. The molecular constructs were cloned in the
E. coli strain Top10, which was  conﬁrmed by molecular methods
(colony PCR and sequencing) and were transfected by electro-
poration into L. major. As for the transfection, a DNA fragment
extracted from recombinant vectors containing the antibiotic resis-
tance genes (Neomycin and Hygromycin B) which were ﬂanked by
5F and 3F sequences, was  used. Both of vectors were digested with
SwaI to produce linear fragments for transfection (5F-NEO-3F and
5F-HYG-3F, termed NEOr and HYGr cassettes). The fragments were
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uriﬁed from the gel (agarose gel extraction Kit, Jena Bioscience,
ermany) before electroporation.
.4. Transfection
Log phase wild-type (WT) promastigotes parasites were cen-
rifuged (3000 rpm, 10 min, at 4 ◦C), washed in PBS buffer 2 times
1.75 mM KH2PO4, 8 mM Na2HPO4, 137 mM NaCl, 0.25 mM KCl; pH
.2) and parasites were resuspended at 4 × 107 parasites/ml in cold
ypoOsmolaric Buffer (HOB, Eppendorf) and kept on ice for 10 min
0.4 ml  per transfection). Then, 10 g DNA was  added to 20 l
soOsmolaric Buffer (IOB, Eppendorf) to 0.4 ml  cells, mixed well and
ransferred to electroporation cuvette kept on ice. It was  pulsed
ith Multiporator (Eppendorf, Germany) for d = 2 mm cuvettes at
000 V and 160  s and returned to wet ice for exactly 10 min.
lectroporated parasites were kept in a liquid medium without
ntibiotics for one day prior to selection.
To isolate the clones that contained the resistance gene,
ransfected parasites were gathered by centrifugation (3000 rpm,
0 min, at 4 ◦C) and plated on to semi-solid DMEM media con-
aining 1% agar in the presence of 50 g/ml LEXSY Neo antibiotic
Jena Bioscience, Germany). The isolated clones were cultured in
 liquid medium with of 50 g/ml LEXSY Neo antibiotic. For the
econd round of the transfection, both LEXSY Neo antibiotic at
0 g/ml and LEXSY Hygro antibiotic at 100 g/ml (Jena Bioscience,
ermany) were used for the selection of homozygote clones. For
egative control in tests, WT  parasites were electroporated without
NA.
.5. Genotypes conﬁrmation of mutant parasite
DNA was extracted from the promastigotes by Tissue (plus) SV
ini kit (GeneAll, South Korea). To conﬁrm the correct integration
f the resistance gene into the GPI12 site, Southern blot and PCR
ere performed. The presence of the resistance gene was conﬁrmed
y PCR and by using speciﬁc forward and reverse primers (forward:
egn1F 5-GAGGGTGACGGTGCCTATTT-3 and reverse: Regn1R 5-
CTTCCCGCTTCAGTGACAA-3). The forward primer (Regn1F) was
or a sequence outside the targeted gene while the reverse primer
Regn1R) anneals within the NEOr gene and the forward: A3804 5-
CGATGGCTGTGTAGAAGTACTCG-3 anneals within the HYGr gene
nd reverse: Reg2R 5-GAAACAGGATGGTACGGCTTGGA-3 for a
equence outside the targeted gene.
Probes (HYGr and NEOr) were produced by labelling the PCR
roduct with Biotin by using Biotin PCR Labelling Core Kit (Jena
iosience, Germany) according to manufacturer’s instructions. To
onﬁrm the presence of the resistance gene in the mutant’s genome
nd make a probe, internal primers of neomycin resistance gene
forward: neoF 5-GACTGGTTGCTATTGGGCGA-3; reverse neoR 5-
AATCCAGAAAAGCGGCCAT-3) and hygromycin resistance gene
forward hygf 5-CTCGGAGGGCGAAGAATCTC-3; reverse hygr 5-
CGTCCATCACAGTTTGCCA-3) were used. In Southern blot test,
NA from WT  and mutant parasite were digested with FseI  and
indIII restricted enzymes and separated on a 0.8% agarose gel then
hey were transferred on to a nylon membrane (Roche, Germany)
Sambrook and Russell, 2001).
.6. Detection of mRNA by RT-PCR
The total RNA from parasites was isolated by Total RNA Puriﬁ-
ation Kit (Jena Biosience, Germany). cDNA was  synthesized from
0 ng of the total RNA using the AccuPower RocketScript RT PreMix
ith oligo-dT primers. cDNA was ampliﬁed with speciﬁc primer
f the GPI12 gene (forward = CDf 5-GACTTGCAAGACGGCATGTG-3;
everse = CDR 5-AGACTGATGCGGGTGGAATG-3).pica 154 (2016) 63–72 65
2.7. Western blot of GPI12 protein
Promastigotes were centrifuged (3000 rpm for 15 min) and the
supernatant discarded and the pellets washed twice with PBS
buffer. The pellets were then lysed using SDS-PAGE (2×)  sample
buffer (4.5 mM Tris–HCl, pH 6.8, 2% w/v SDS, 10% v/v glycerol, 0.05%
w/v bromophenol blue, 5% v/v 2-mercaptoethanol) that were added
to the pellets on ice and then boiled for 5 min (Bolhassani et al.,
2011). Proteins from WT and mutant parasites were separated by
SDS-PAGE in a 12% polyacrylamide gel (SDS gel electrophorese;
Clever, UK). For western blot, the separated proteins were trans-
ferred onto the PVDF transfer membrane (Sigma, Germany) by
using a Bio-Rad semi-dry blotting system. The PVDF membrane
was soaked with TBST solution (150 mM NaCl, 10 mM Tris–HCl, pH
7.4 and 0.1% Tween 20) with 3% skimmed milk for 2 h and then
reacted with antibodies against the linear epitopes GPI12 protein.
These epitopes were from the Genscript Company (USA) for pro-
ducing antibodies and puriﬁcation in rabbits. The membrane was
washed and the secondary antibody (Goat anti-rabbit IgG alkaline
phosphatase conjugate) was added and incubated, after washing,
the substrate solution (NBT/BCIP) was added and incubated at room
temperature in dark conditions.
2.8. In vitro studies
The murine macrophage (MQ) cell line J774 was  grown in
DMEM high glucose (4.5 g/l) media (Biosera, France), with 10%
foetal bovine serum (Gibco, UK), 40 mM HEPES, 2 mM l-glutamine
and 1% PenSterp in tissue culture ﬂask and incubated at 37 ◦C in
5% CO2 for 3 days. After preparing the macrophages, we counted
them and then added 500,000 MQ cells to each well of a microplate
and incubated them at 37 ◦C in 5% CO2 for 1 h to attach them to the
plate.
For infecting the MQ,  the stationary phase promastigotes from
WT and mutants were added at the ratio of 5:1 (parasites to MQ)
and again incubated at 37 ◦C in 5% CO2 for 1 h. To exclude the free
parasites, the supernatants were peptized and then 400 l of com-
plemented DMEM medium was  added to each well and at 6, 24, 48
and 72 h of the experiment, the contents of the wells were removed
by pipetting and transferred to a microtube and then centrifuged
(1800 rpm, 5 min, 4 ◦C) and the supernatant discarded. Then, the
sediment was  smeared on a slide and ﬁxed with methanol and
stained by Giemsa and observed under a microscope.
One hundred MQ  were evaluated in each coverslip then the per-
centage of the infected MQ  and the mean number of parasites per
MQ were calculated. The experiments were performed three times
at different time points.
2.9. In vivo studies
Forty female BALB/c mice weighing 20–25 g and aged 6–8 weeks
were obtained from the animal house of Kerman University of
Medical Sciences. The animals were fed with standard food and
water and keep under standard conditions: temperature 20–23 ◦C,
55 ± 10% relative humidity with a 12 h light and dark cycle, in a
pathogen free environment. They were randomly allocated into 2
groups (n = 20).
Each group was  inoculated subcutaneously at the base of the tail
with 1 × 106 stationary promastigotes of mutant or WT  parasites.
The lesion size was measured weekly, using a metric calliper. Mice
were euthanized at different time intervals and tissues including
lymph node and skin from the base of the tail were gathered from
each group (three mice randomly per group selected at each spe-
ciﬁc period) and evaluated for live parasites by culturing in DMEM
medium with 10% FBS (and LEXSY Neo, HYGR antibiotics for mutant
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arasites). Also, PCR was performed to conﬁrm the mutant para-
ites.
.10. Quantiﬁcation of parasite load
To quantify the parasite load, lymph node and skin from the
ase of the tail were collected from two mice from each group at
ifferent time points post infection. Genomic DNA was  extracted
rom 20 mg  of tissue with Tissue (plus) SV mini (GeneAll, South
orea). Reaction was performed by using 100 ng of the DNA, 5 pmol
f RV1 (forward: 50-CTTTTCTGGTCCCGCGGGTAGG-30) and RV2
reverse: 50-CCACCTGGCCTATTTTACACCA-30) primers (Lachaud
t al., 2002) and 5 l Qiagen QuantiFast SYBR Green Mastermix
Qiagen, Germany) in a total volume of 12 l with the following
mpliﬁcation program: 95 ◦C for 5 min, 25 cycles of 94 ◦C for 15 s,
0 ◦C for 20 s, and 72 ◦C for 20 s in an Rotor Gene Q real time system
Qiagen, Germany). The DNA of normal mouse skin at the base of
he tail and WT  were used as negative and positive controls, respec-
ively. For drawing the standard curve the WT  DNA in dilution series
.1–105 parasites was used.
.11. Statistical analysis
The statistical analysis between the two groups done by Stu-
ent’s t-test using SPSS software. The differences were considered
igniﬁcant at p < 0.05. The data was presented as means ± SD.
. Results
.1. The genotypic analysis
For verifying the knock out GPI12 gene by resistance genes we
valuated the DNA of mutants by PCR and Southern blot tests.
ntibiotic resistance gene integration was conﬁrmed by using
rimers Regn1R and Regn1F. Fig. 2 shows 1.9-kb amplicon repre-
enting NEOr (Fig. 2A, lane 2, 3); yet, WT  has no speciﬁc ampliﬁed
and (Fig. 2A, lanes 4, 5). Fig. 2B shows 1.4-kb amplicon represent-
ng HYGr integration (Fig. 2B, lanes 2, 4) and WT  has no speciﬁc
mpliﬁed band (Fig. 2B, lanes 3, 5).
For Southern blot, DNA from WT  and mutants was digested with
seI and HindIII and hybridized with the Biotin-labelled NEOr and
YGr probe (Fig. 3A, C, and D). The results showed that neomycin
robe was hybridized to a 4.4-kb fragment and the hygromycin
robe was hybridized to a 4.6-kb fragment in the mutant parasites.
n contrast no hybridization of probes with WT  genomic DNA was
een (Fig. 3B).
.2. Morphological properties of the parasites
The size of promastigotes in the WT and mutant was measured
nd compared daily using a microscope eyepiece micrometre after
taining with Giemsa. The light microscopy observation shows that
utant parasites are not different in their shape and size in com-
arison to the WT  parasites.
.3. The gene expression of GPI12
The expression of GPI12 was examined by RT-PCR. As it is shown
n Fig. 4, the ampliﬁcation of a 328 bp band in the cDNA of the WT
romastigotes conﬁrmed the presence of GPI12 and its expression
Fig. 4, lanes 2 and 3); however, in the cDNA of the mutant parasite,
o speciﬁc ampliﬁed band was observed and the absence of GPI12
nd its expression was conﬁrmed (Fig. 4, lanes 4 and 5).pica 154 (2016) 63–72
3.4. Protein production
To check the protein production in the mutants and WT par-
asites, Western blot analysis was  performed. Anti- GPI12 linear
epitopes were able to recognize the 28.8 kDa protein band rele-
vant to GPI12 in the WT  parasites (Fig. 5, lanes 2 and 3) and the
mutant parasites (Fig. 5, lanes 4 and 5) no speciﬁc band conﬁrmed
the absence of the GPI12 protein product. This conﬁrms the data
obtained with RT-PCR.
3.5. In vitro study
J774 cell line MQ  was  used to examine the inﬂuence of GPI12
disruption on the infectivity and survival of L. major in in vitro
condition. In Giemsa stained infected cells, each parasite was  dis-
tinctly observed by the light microscope. Six hours after infection,
the mutant parasites were attached and entered the macrophages
(41.67 ± 1.12%; n = 3), although at a lower level in contrast to the WT
parasites (97.67 ± 1.52%; n = 3). Within the 2 days post-infection,
the mutants parasites were able to infect the MQ,  however, the
total number of the infected MQ  was lower in comparison with the
WT parasites (p < 0.05) (Fig. 6A). The percentage of the infected MQ
with mutant parasites decreased by 72 h after the infection.
The total number of the parasites in one hundred macrophages
was also recorded at different time points. The parasite count was
lower in the mutants (613.33 ± 24; n = 3) in comparison with the
WT parasites (1325.66 ± 25.54; n = 3) 6 h after the infection (Fig. 6B).
The difference between the number of the mutant parasites and
the WTs  was  more evident at 72 h after the infection (p < 0.05). The
total number of the parasites inside the MQs  decreased differently
in both cases. It seems that the lack of the GPI12 has direct inﬂuence
on the parasite loads in the MQ.  This result suggests that GPI12 has
an important role in the attachment, survival and replication of
parasites in MQ.
3.6. In vivo study
We  evaluated the ability of the mutant parasites in causing
infection and lesions in BALB/c mice (Fig. 7A). The mice infected
with wild-type L. major begun to develop lesions after 4 weeks and
the skin at the base of the tail lesion increased (Fig. 7C and D).  The
mutant parasites could not create cutaneous lesions in the skin at
the base of the tail of the infected mice even at six months after
infection (Fig. 7B). At different time points (2, 4 and 8 weeks), in
the two  groups (wild and mutant) the infected lymph nodes were
cultured in a complete media without or with (for mutant) any
antibiotic, and motile and live parasites were detected.
In addition, we  compared the number of the parasites in the skin
at the base of the tail and the lymph nodes at 4 to 12 weeks after
infection. The DNA obtained from these two  sites was extracted to
check parasite burden quantiﬁcation by real-time PCR as shown
in Fig. 8. The differences were signiﬁcant at different time points
(p < 0.05).
4. Discussion
The GPI12 gene located in chromosome 9, Lmjchr9,
LMJF 09 0040 749 bp. This gene encodes a protein with 249
amino acids. GlcNAc-PI-de-N-acetylase is an essential step required
for all GPI biosynthetic pathways. The goal of present study was
to examine the role of GPI12 in the differentiation, growth and
infectivity of L. major through gene disruption. We  showed that
two alleles of GPI12 gene in L. major were successfully removed
and were enabled to generate the null mutant, which supports
the idea that GPI12 appears to not be an essential gene for the
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rowth and survival of Leishmania and the homozygous knockouts
f Leishmania are able to survive.
In this study, we observed that the mutant promastigotes had
he same morphological properties in comparison with the WT
romastigotes.
An in vitro study using murine MQ  cell line J774, showed that by
he use of recombinant parasites the entry rate and infecting ability
as decreased.
As for the mutant parasites, they were unable to produce skin
esions even six months post-infection in the BALB/c mice. This data
onﬁrms our observation in the in vitro cultured MQ.
ig. 2. Conﬁrmation of antibiotic resistance gene integration by PCR in mutant parasites: 
he  speciﬁc band of 1.9 kb in mutant parasites with NEOr, In the WT,  as shown in lanes 4 a
mplicon which represents HYGr integration in lanes 2 and 4 while WT DNA has no speci
ig. 3. Southern blot analysis of genomic DNA. (A) Restriction enzyme sites. (B) Genom
seI  and HindIII and hybridized with NEOr and HYGr gene as probe. Lane 1 is the DNA m
ybridized with NEOr. Lane 4—L. major wild-type parasite as the control for HYGr. Lane 5pica 154 (2016) 63–72 67
In general, the mutant parasites that grow within macrophages
were divided into three categories: (1) mutant parasites that
cause latency ulcers in sensitive mice, which are a defect in the
early stages of infection. Such parasites are unable to perform the
process of differentiation of procyclic promastigotes into infec-
tive metacyclic promastigotes and their invasion and survival in
macrophages. The amastigote forms of these mutant parasites pass
a natural course of proliferation and survival in the MQ  cells. (2)
Those parasites which can be differentiated into amastigotes within
macrophages and in mice but which do not survive, and as a result
the infection disappears after a relatively short time. (3) Those par-
asites that are capable of living without causing any harm (Myler
(A) isolated clones with PCR using primers Regn1R and Regn1F. Lanes 2 and 3 show
nd 5, no speciﬁc band was seen, Lane 1 is the ladder of DNA. (B) This shows 1.4-kb
ﬁc band in lanes 3 and 5 and Lane 1 is the ladder of DNA.
ic DNA derived from L. major wild-type and mutant parasite were digested with
olecular weight marker. Lane 2—mutants hybridized with HYGr. Lane 3—mutants
—L. major wild-type parasite as the control for NEOr. (C) NEOr and (D) HYGr probe.
68 P.G.N. Almani et al. / Acta Tropica 154 (2016) 63–72
Fig. 4. Expression analysis of GPI12in mutant and WT parasites. The RT-PCR tests using the cDNA of WT (lanes 2 and 3) and mutant parasites (lanes 4 and 5) with GPI12
speciﬁc primers. The ampliﬁed 328 bp band conﬁrmed mRNA GPI12 expression only in the wild strain. Lane 1 shows the molecular ladder.
F able t
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cig. 5. Western blot test. The GPI12 detected by using anti- GPI12 linear epitopes 
utant  parasites there were no speciﬁc protein bands (lanes 4 and 5). Lane 1 prese
nd Fasel, 2008). According to the present research recombinant
arasites are placed in the third group.
According to different reports, the essential genes in the parasite
ife cycle that have been identiﬁed in the multi-level segmentation
re as follows: (a) genes that are essential for live promastigotes in
ulture. It includes the deletion of both alleles of the genes, which
s not that easily performed. They are associated with gene ampliﬁ-
ation, Trisomy or Tetrasomy, or they are observed in circle shapeso recognize the 28.8 kDa protein band in WT parasite (lanes 2 and 3) however, in
e protein marker.
and their proliferation happens as extra-chromosomal, which later
remains in the cell. These group of genes are cited as genes such as
DHFR-TS (Cruz et al., 1991; Cruz et al., 1993), alpha tubulin (Curotto
de Lafaille and Wirth, 1992), Crk1 (Mottram et al., 1996) and try-
panothione reductase (Dumas et al., 1997). In some cases, deleting a
gene only in the presence of a copy of that in episomal form is possi-
ble for example Topoisomerase gene (Balan˜a-Fouce et al., 2008). (b)
Parasite genes which are essential in the differentiation of the pro-
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F d 72 h
a ls at d
m
L
t
G
mig. 6. (A) Percentage of MQ  infected with WT and mutant parasites in 6, 24, 48 an
s  the mean ± SD. (B) The total number of the parasites within one hundred MQ cel
astigote to amastigote or even the proliferation of amastigotes,
IT1 (Huynh et al., 2006) gene is placed in this group. (c) Genes
hat play an important role in the pathogenesis of macrophages;
DPMP gene (Garami and Iiq, 2001) for example. Leishmania with
olecules such as LPG, GP63 and cysteine protease is capable of. The total number of the MQ and infected MQ were calculated. Data was reported
ifferent time points post-infection. All tests were performed in triplicate.
establishing infection in parasitophorous vacuole in macrophages
(Chang and McGwire, 2002). It seems that the GPI12 gene could be
placed in the third group.
A common feature among most species of Leishmania is their
ability for survival and reproduction among acidic phagolysosomes
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hich contain hydrolase enzymes. This is one of the necessary con-
itions for the parasite’s infectivity and for the severity of diseases
aused by Leishmania proliferation within macrophages. In fact,
utations in genes which are involved in the primary infection of
acrophages and the survival of the cells reduced the severity and
elayed the wound formation (Huynh et al., 2006).
In this study we were able to isolate live and motile mutant
arasites from infected lymph nodes which were cultured in com-
lete media. It is likely that these genes are not necessary for the
eplication and viability of promastigotes in in vitro culture. There
re other reports of genes with similar results such as the cysteine
ig. 7. In vivo study. (A) Mice infected with parasites in the skin at the base of the tail. (B
nfection. (C) Mice infected with wild-type L. major begun to develop lesions after 4 week
t  the base of the tail was measured.pica 154 (2016) 63–72
proteinase B gene, which acts as a virulence factor and is not neces-
sary for in vitro growth and differentiation (Mottram et al., 1996).
Another example is L. major lpg2 null mutant which could not
generate in vivo disease (Kébaïer et al., 2006).
Virulence is inﬂuenced by two different groups of parasite
molecules: one group is the vast majority of products secreted by
the parasite surface and the other is intracellular molecules encom-
passing the so-called pathoantigens and the generally conserved
proteins in the cytoplasm. This causes an immune response against
intracellular parasite antigens.
) The mutant parasites could not create cutaneous lesions until after six months of
s and increased. (D) In the two groups (wild and mutant), the lesion size in the skin
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F o gro
n
a
i
2ig. 8. Real-time PCR quantiﬁcation of the parasites: The DNA obtained from the tw
odes  (B) to perform parasite load by real-time PCR at different time periods.
The immune responses against a surface or secreted molecules
re low. In fact, many of these molecules contribute to parasite
nfection in the host cells (Chang and McGwire, 2002; Chang et al.,
003).ups of the mice was isolated from the skin at the base of the tail (A) and the lymph
Today, a new generation of genetically attenuated live vaccines
are manufactured and evaluated in Leishmania. The salient fact
about this generation of vaccines is that they maintain the original
form of the parasite antigens, while making speciﬁc genetic modi-
ﬁcations in the Leishmania genome by using gene targeted deletion
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echnology through homologous recombination. It is possible to
roduce parasites which lack the genes necessary for long-term
urvivals or virulences.
In this study, we were able to produce mutant parasite that
as unable to damage the host; while at the same time containing
athoantigen proteins which are effective in establishing immu-
ity. Further investigations are essential to check the safety proﬁle
n laboratory animals.
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